Functionalized upconversion nanoparticles: Versatile nanoplatforms for translational research

Current Molecular Medicine

Volumn 13, Issue 10, 2013, Pages 1613-1632

  Chen, F ^a   Bu, W ^a   Cai, W ^b   Shi, J ^a  

^a SHANGHAI INSTITUTE OF CERAMICS   (China)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Molecular imaging; Multimodality probe; Personalized therapy; Translational research; Upconversion nanoparticle (UCNP)

Indexed keywords

1 BUTYL 3 METHYLIMIDAZOLIUM TETRAFLUOROBORATE; CONTRAST MEDIUM; COPPER 64; FLUORINE 18; FUNCTIONALIZED UPCONVERSION NANOPARTICLE; GADOLINIUM; IOBITRIDOL; MACROGOL; METHYLENE BLUE; NANOPARTICLE; POLYACRYLIC ACID; TETRAETHOXYSILANE; UNCLASSIFIED DRUG; YTTERBIUM;

ATOMIC EMISSION SPECTROMETRY; CANCER DIAGNOSIS; CELL TRACKING; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; FLUORESCENCE IMAGING; HUMAN; MOLECULAR IMAGING; NEAR INFRARED SPECTROSCOPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERSONALIZED MEDICINE; PHOTOLUMINESCENCE; POSITRON EMISSION TOMOGRAPHY; REVIEW; TRANSLATIONAL RESEARCH; TRANSMISSION ELECTRON MICROSCOPY; X RAY PHOTOELECTRON SPECTROSCOPY;

BIOCOMPATIBLE MATERIALS; DIAGNOSTIC IMAGING; HUMANS; LANTHANOID SERIES ELEMENTS; NANOPARTICLES; NEOPLASMS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84889055429     PISSN: 15665240     EISSN: 18755666     Source Type: Journal    
DOI: 10.2174/1566524013666131111122133     Document Type: Review

References (138)

1. Nie S, Xing Y, Kim GJ, Simons JW. Nanotechnology applications in cancer. In: editors. Ann Rev B E 2007. p. 257-88.
2. Ferrari M. Cancer nanotechnology: Opportunities and challenges. Nat Rev Cancer 2005; 5: 161-71.
3. Brigger I, Dubernet C, Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev 2002; 54: 631-51.
4. Massoud TF, Gambhir SS. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 2003; 17: 545-80.
5. Alauddin MM. Positron emission tomography (PET) imaging with 18F-based radiotracers. Am J Nucl Med Mol Imaging 2012; 2: 55-76.
6. Grassi I, Nanni C, Allegri V, et al. The clinical use of PET with 11C-acetate. Am J Nucl Med Mol Imaging 2012; 2: 33-47.
7. Eary JF, Hawkins DS, Rodler ET, Conrad EUI. 18F-FDG PET in sarcoma treatment response imaging. Am J Nucl Med Mol Imaging 2011; 1: 47-53.
8. Bhargava P, He G, Samarghandi A, Delpassand ES. Pictorial review of SPECT/CT imaging applications in clinical nuclear medicine. Am J Nucl Med Mol Imaging 2012; 2: 221-31.
9. Aparici CM, Carlson D, Nguyen N, Hawkins RA, Seo Y. Combined SPECT and Multidetector CT for Prostate Cancer Evaluations. Am J Nucl Med Mol Imaging 2012; 2: 48-54.
10. Chin PTK, Beekman CAC, Buckle T, Josephson L, van Leeuwen FWB. Multispectral visualization of surgical safety- margins using fluorescent marker seeds. Am J Nucl Med Mol Imaging 2012; 2: 151-62.
11. Huang X, Lee S, Chen X. Design of "smart" probes for optical imaging of apoptosis. Am J Nucl Med Mol Imaging 2011; 1: 3-17.
12. Cai WB, Rao JH, Gambhir SS, Chen XY. How molecular imaging is speeding up antiangiogenic drug development. Mol Cancer Ther 2006; 5: 2624-33.
13. Tandon P, Nordstrom RJ. Next-generation imaging development for nanoparticle biodistribution measurements. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2011; 3: 5-10.
14. Weissleder R. Molecular Imaging in Cancer. Science 2006; 312: 1168-71.
15. Rudin M, Weissleder R. Molecular imaging in drug discovery and development. Nat Rev Drug Discov 2003; 2: 123-31.
16. Cai WB, Chen XY. Nanoplatforms for targeted molecular imaging in living subjects. Small 2007; 3: 1840-54.
17. Abeylath SC, Ganta S, Iyer AK, Amiji M. Combinatorial Designed Multifunctional Polymeric Nanosystems for Tumor Targeted Therapeutic Delivery. Acc Chem Res 2011; 44: 1009-17.
18. Al-Jamal WT, Kostarelos K. Liposomes: From a Clinically Established Drug Delivery System to a Nanoparticle Platform for Theranostic Nanomedicine. Acc Chem Res 2011; 44: 1094-104.
19. Ambrogio MW, Thomas CR, Zhao Y-L, Zink JI, Stoddart JF. Mechanized Silica Nanoparticles: A New Frontier in Theranostic Nanomedicine. Acc Chem Res 2011; 44: 903-13.
20. Bardhan R, Lal S, Joshi A, Halas NJ. Theranostic Nanoshells: From Probe Design to Imaging and Treatment of Cancer. Acc Chem Res 2011; 44: 936-46.
21. Barreto JA, O'Malley W, Kubeil M, et al. Nanomaterials: Applications in Cancer Imaging and Therapy. Adv Mater 2011; 23: H18-H40.
22. Cabral H, Nishiyama N, Kataoka K. Supramolecular Nanodevices: From Design Validation to Theranostic Nanomedicine. Acc Chem Res 2011; 44: 999-1008.
23. Cheng Y, Zhao L, Li Y, Xu T. Design of biocompatible dendrimers for cancer diagnosis and therapy: current status and future perspectives. Chem Soc Rev 2011; 40: 2673-703.
24. Della Rocca J, Liu D, Lin W. Nanoscale Metal-Organic Frameworks for Biomedical Imaging and Drug Delivery. Acc Chem Res 2011; 44: 957-68.
25. Dreaden EC, Mackey MA, Huang X, Kang B, El-Sayed MA. Beating cancer in multiple ways using nanogold. Chem Soc Rev 2011; 40: 3391-404.
26. Ho D, Sun X, Sun S. Monodisperse Magnetic Nanoparticles for Theranostic Applications. Acc Chem Res 2011; 44: 875-82.
27. Lee JE, Lee N, Kim T, Kim J, Hyeon T. Multifunctional Mesoporous Silica Nanocomposite Nanoparticles for Theranostic Applications. Acc Chem Res 2011; 44: 893-902.
28. Xia Y, Li W, Cobley CM, et al. Gold Nanocages: From Synthesis to Theranostic Applications. Acc Chem Res 2011; 44: 914-24.
29. Yoo D, Lee J-H, Shin T-H, Cheon J. Theranostic Magnetic Nanoparticles. Acc Chem Res 2011; 44: 863-74.
30. Sun M, Hoffman D, Sundaresan G, et al. Synthesis and characterization of intrinsically radio-labeled quantum dots for bimodal detection. Am J Nucl Med Mol Imaging 2012; 2: 122-35.
31. Cai W, Hong H. In a "nutshell": intrinsically radio-labeled quantum dots. Am J Nucl Med Mol Imaging 2012; 2: 136-40.
32. Yigit MV, Medarova Z. In vivo and ex vivo applications of gold nanoparticles for biomedical SERS imaging. Am J Nucl Med Mol Imaging 2012; 2: 232-41.
33. Zhou J, Liu Z, Li F. Upconversion nanophosphors for small animal imaging. Chem Soc Rev 2012; 41: 1323-49.
34. Auzel F. Upconversion and Anti-Stokes Processes with f and d Ions in Solids. Chem Rev 2003; 104: 139-74.
35. Haase M, Schäfer H. Upconverting Nanoparticles. Angew Chem Int Ed 2011; 50: 5808-29.
36. Wang J, Wang F, Wang C, Liu Z, Liu XG. Single-Band Upconversion Emission in Lanthanide-Doped KMnF(3) Nanocrystals. Angew Chem Int Ed 2011; 50: 10369-72.
37. Ju Q, Tu D, Liu Y, et al. Amine-Functionalized Lanthanide Doped KGdF4 Nanocrystals as Potential Optical/Magnetic Multimodal Bioprobes. J Am Chem Soc 2011; 134: 1323-30.
38. Wu SW, Han G, Milliron DJ, et al. Non-blinking and photostable upconverted luminescence from single lanthanide-doped nanocrystals. Proc Natl Acad Sci USA 2009; 106: 10917-21.
39. Cheng LA, Yang K, Zhang SA, et al. Highly-Sensitive Multiplexed in vivo Imaging Using PEGylated Upconversion Nanoparticles. Nano Res 2010; 3: 722-32.
40. Park YI, Kim JH, Lee KT, et al. Nonblinking and Nonbleaching Upconverting Nanoparticles as an Optical Imaging Nanoprobe and T1 Magnetic Resonance Imaging Contrast Agent. Adv Mater 2009; 21: 4467-71.
41. Liu Q, Sun Y, Yang T, et al. Sub-10 nm Hexagonal Lanthanide-Doped NaLuF4 Upconversion Nanocrystals for Sensitive Bioimaging in Vivo. J Am Chem Soc 2011; 133: 17122-5.
42. Nam SH, Bae YM, Park YI, et al. Long-Term Real-Time Tracking of Lanthanide Ion Doped Upconverting Nanoparticles in Living Cells. Angew Chem Int Ed 2011; 50: 6093-7.
43. Xiong L, Chen Z, Tian Q, et al. High Contrast Upconversion Luminescence Targeted Imaging in Vivo Using PeptideLabeled Nanophosphors. Anal Chem 2009; 81: 8687-94.
44. Kobayashi H, Kosaka N, Ogawa M, et al. In vivo multiple color lymphatic imaging using upconverting nanocrystals. J Mater Chem 2009; 19: 6481-4.
45. Kumar R, Nyk M, Ohulchanskyy TY, Flask CA, Prasad PN. Combined Optical and MR Bioimaging Using Rare Earth Ion Doped NaYF4 Nanocrystals. Adv Funct Mater 2009; 19: 853-9.
46. Chen F, Bu W, Zhang S, et al. Positive and Negative Lattice Shielding Effects Co-existing in Gd (III) Ion Doped Bifunctional Upconversion Nanoprobes. Adv Funct Mater 2011; 21: 4285-94.
47. Gorris HH, Ali R, Saleh SM, Wolfbeis OS. Tuning the Dual Emission of Photon-Upconverting Nanoparticles for Ratiometric Multiplexed Encoding. Adv Mater 2011; 23: 1652-5.
48. Zhang F, Shi Q, Zhang Y, et al. Fluorescence Upconversion Microbarcodes for Multiplexed Biological Detection: Nucleic Acid Encoding. Adv Mater 2011; 23: 3775-9.
49. Xiong L, Yang T, Yang Y, Xu C, Li F. Long-term in vivo biodistribution imaging and toxicity of polyacrylic acid-coated upconversion nanophosphors. Biomaterials 2010; 31: 7078-85.
50. Cheng L, Yang K, Li Y, et al. Facile Preparation of Multifunctional Upconversion Nanoprobes for Multimodal Imaging and Dual-Targeted Photothermal Therapy. Angew Chem Int Ed 2011; 50: 7385-90.
51. Liu Y, Ai K, Liu J, et al. A High-Performance Ytterbium-Based Nanoparticulate Contrast Agent for In Vivo X-Ray Computed Tomography Imaging. Angew Chem Int Ed 2012; 51: 1437-42.
52. Chatterjee DK, Rufaihah AJ, Zhang Y. Upconversion fluorescence imaging of cells and small animals using lanthanide doped nanocrystals. Biomaterials 2008; 29: 937-43.
53. Wang F, Banerjee D, Liu YS, Chen XY, Liu XG. Upconversion nanoparticles in biological labeling, imaging, and therapy. Analyst 2010; 135: 1839-54.
54. Mai HX, Zhang YW, Si R, et al. High-quality sodium rareearth fluoride nanocrystals: Controlled synthesis and optical properties. J Am Chem Soc 2006; 128: 6426-36.
55. Qian HS, Zhang Y. Synthesis of Hexagonal-Phase CoreShell NaYF4 Nanocrystals with Tunable Upconversion Fluorescence. Langmuir 2008; 24: 12123-5.
56. Boyer JC, Cuccia LA, Capobianco JA. Synthesis of colloidal upconverting NaYF4: Er3+/Yb3+ and Tm3+/Yb3+ monodisperse nanocrystals. Nano Lett 2007; 7: 847-52.
57. Li ZQ, Zhang Y. An efficient and user-friendly method for the synthesis of hexagonal-phase NaYF4: Yb, Er/Tm nanocrystals with controllable shape and upconversion fluorescence. Nanotechnology 2008; 19: 5.
58. Wang F, Han Y, Lim CS, et al. Simultaneous phase and size control of upconversion nanocrystals through lanthanide doping. Nature 2010; 463: 1061-5.
59. Wang X, Zhuang J, Peng Q, Li YD. A general strategy for nanocrystal synthesis. Nature 2005; 437: 121-4.
60. Wang F, Wang J, Liu X. Direct Evidence of a Surface Quenching Effect on Size-Dependent Luminescence of Upconversion Nanoparticles. Angew Chem Int Ed 2010; 49: 7456-60.
61. Wang F, Deng R, Wang J, et al. Tuning upconversion through energy migration in core-shell nanoparticles. Nat Mater 2011; 10: 968-73.
62. Chen G, Ohulchanskyy TY, Kumar R, Ågren H, Prasad PN. Ultrasmall Monodisperse NaYF4:Yb3+/Tm3+ Nanocrystals with Enhanced Near-Infrared to Near-Infrared Upconversion Photoluminescence. ACS Nano 2010; 4: 3163-8.
63. Johnson NJJ, Oakden W, Stanisz GJ, Scott Prosser R, van Veggel FCJM. Size-Tunable, Ultrasmall NaGdF4 Nanoparticles: Insights into Their T1 MRI Contrast Enhancement. Chem Mater 2011; 23: 3714-22.
64. Boyer J-C, van Veggel FCJM. Absolute quantum yield measurements of colloidal NaYF4: Er3+, Yb3+ upconverting nanoparticles. Nanoscale 2010; 2: 1417-9.
65. Soo Choi H, Liu W, Misra P, et al. Renal clearance of quantum dots. Nat Biotech 2007; 25: 1165-70.
66. Guo H, Li ZQ, Qian HS, Hu Y, Muhammad IN. Seedmediated synthesis of NaYF(4):Yb, Er/NaGdF(4) nanocrystals with improved upconversion fluorescence and MR relaxivity. Nanotechnology 2010; 21: 125602-8
67. Abel KA, Boyer J-C, Veggel FCJMv. Hard Proof of the NaYF4/NaGdF4 Nanocrystal Core/Shell Structure. J Am Chem Soc 2009; 131: 14644-5.
68. Abel KA, Boyer J-C, Andrei CM, van Veggel FCJM. Analysis of the Shell Thickness Distribution on NaYF4/NaGdF4 Core/Shell Nanocrystals by EELS and EDS. J Phys Chem Lett 2011; 2: 185-9.
69. Zhang Y, Hong H, Engle JW, et al. Positron emission tomography and near-infrared fluorescence imaging of vascular endothelial growth factor with dual-labeled bevacizumab. Am J Nucl Med Mol Imaging 2012; 2: 1-13.
70. Thorek DLJ, Robertson R, Bacchus WA, et al. Cerenkov imaging a new modality for molecular imaging. Am J Nucl Med Mol Imaging 2012; 2: 163-73.
71. Cai W, Zhang Y, Kamp TJ. Imaging of induced pluripotent stem cells: from cellular reprogramming to transplantation. Am J Nucl Med Mol Imaging 2011; 1: 18-28.
72. Zhang Y, Cai W. Molecular imaging of insulin-like growth factor 1 receptor in cancer. Am J Nucl Med Mol Imaging 2012; 2: 248-59.
73. Nyk M, Kumar R, Ohulchanskyy TY, Bergey EJ, Prasad PN. High Contrast in Vitro and in Vivo Photoluminescence Bioimaging Using Near Infrared to Near Infrared Up- Conversion in TM3+ and Yb3+ Doped Fluoride Nanophosphors. Nano Lett 2008; 8: 3834-8.
74. Zhou J, Sun Y, Du XX, et al. Dual-modality in vivo imaging using rare-earth nanocrystals with near-infrared to near- infrared (NIR-to-NIR) upconversion luminescence and magnetic resonance properties. Biomaterials 2010; 31: 3287-95.
75. Xing H, Bu W, Zhang S, et al. Multifunctional nanoprobes for upconversion fluorescence, MR and CT trimodal imaging. Biomaterials 2012; 33: 1079-89.
76. Chen F, Zhang S, Bu W, et al. A "Neck-Formation" Strategy for an Antiquenching Magnetic/Upconversion Fluorescent Bimodal Cancer Probe. Chem Eur J 2010; 16: 11254-60.
77. Xia A, Gao Y, Zhou J, et al. Core-shell NaYF4:Yb3+,Tm3+@FexOy nanocrystals for dual-modality T2-enhanced magnetic resonance and NIR-to-NIR upconversion luminescent imaging of small-animal lymphatic node. Biomaterials 2011; 32: 7200-8.
78. Hou Z, Li C, Ma P, et al. Electrospinning Preparation and Drug-Delivery Properties of an Up-conversion Luminescent Porous NaYF4:Yb3+, Er3+@Silica Fiber Nanocomposite. Adv Funct Mater 2011; 21: 2356-65.
79. Tian G, Gu Z, Zhou L, et al. Mn2+ Dopant-Controlled Synthesis of NaYF4:Yb/Er Upconversion Nanoparticles for in vivo Imaging and Drug Delivery. Adv Mater 2012; 24: 1226-31.
80. Shen J, Sun L-D, Zhu J-D, et al. Biocompatible Bright YVO4:Eu Nanoparticles as Versatile Optical Bioprobes. Adv Funct Mater 2010; 20: 3708-14.
81. Wang J, Wang F, Wang C, Liu Z, Liu X. Single-Band Upconversion Emission in Lanthanide-Doped KMnF(3) Nanocrystals. Angew Chem Int Ed 2011; 50: 10369-72.
82. He M, Huang P, Zhang C, et al. Dual Phase-Controlled Synthesis of Uniform Lanthanide-Doped NaGdF4 Upconversion Nanocrystals Via an OA/Ionic Liquid Two- Phase System for In Vivo Dual-Modality Imaging. Adv Funct Mater 2011; 21: 4470-7.
83. Zhu X, Zhou J, Chen M, et al. Core-shell Fe3O4@NaLuF4:Yb,Er/Tm nanostructure for MRI, CT and upconversion luminescence tri-modality imaging. Biomaterials 2012; 33: 4618-27.
84. Xing H, Bu W, Ren Q, et al. A NaYbF4: Tm3+ nanoprobe for CT and NIR-to-NIR fluorescent bimodal imaging. Biomaterials 2012; 33: 5384-93.
85. Haller C, Hizoh I. The cytotoxicity of iodinated radiocontrast agents on renal cells in vitro. Invest Radiol 2004; 39: 149-54.
86. Hizoh I, Haller C. Radiocontrast-induced renal tubular cell apoptosis - Hypertonic versus oxidative stress. Invest Radiol 2002; 37: 428-34.
87. Liu Q, Chen M, Sun Y, et al. Multifunctional rare-earth self- assembled nanosystem for tri-modal upconversion luminescence/fluorescence/positron emission tomography imaging. Biomaterials 2011; 32: 8243-53.
88. Liu Q, Sun Y, Li CG, et al. (18)F-Labeled Magnetic- Upconversion Nanophosphors via Rare-Earth Cation- Assisted Ligand Assembly. ACS Nano 2011; 5: 3146-57.
89. Sun Y, Yu M, Liang S, et al. Fluorine-18 labeled rare-earth nanoparticles for positron emission tomography (PET) imaging of sentinel lymph node. Biomaterials 2011; 32: 2999-3007.
90. Zhou J, Yu M, Sun Y, et al. Fluorine-18-labeled Gd(3+)/Yb(3+)/Er(3+) co-doped NaYF(4) nanophosphors for multimodality PET/MRI/UCL imaging. Biomaterials 2011; 32: 1148-56.
91. Buckle T, van den Berg NS, Kuil J, et al. Non-invasive longitudinal imaging of tumor progression using an 111indium labeled CXCR4 peptide antagonist. Am J Nucl Med Mol Imaging 2012; 2: 99-109.
92. Cai W, Hong H. Peptoid and positron emission tomography: an appealing combination. Am J Nucl Med Mol Imaging 2011; 1: 76-9.
93. Hong H, Zhang Y, Engle JW, et al. In vivo targeting and positron emission tomography imaging of tumor vasculature with (66)Ga-labeled nano-graphene. Biomaterials 2012; 33: 4147-56.
94. Hong H, Severin GW, Yang Y, et al. Positron emission tomography imaging of CD105 expression with 89Zr-Df- TRC105. Eur J Nucl Med Mol Imaging 2012; 39: 138-48.
95. Hall H, Velikyan I, Blom E, et al. In vitro autoradiography of carcinoembryonic antigen in tissue from patients with colorectal cancer using multifunctional antibody TF2 and 67/68 Ga-labeled haptens by pretargeting. Am J Nucl Med Mol Imaging 2012; 2: 141-50.
96. Hao G, Hajibeigi A, De León-Rodríguez LM, Öz OK, Sun X. Peptoid-based PET imaging of vascular endothelial growth factor receptor (VEGFR) expression. Am J Nucl Med Mol Imaging 2011; 1: 65-75.
97. Zhao R, Wang J, Deng J, Yang W, Wang J. Efficacy of 99mTc- EDDA/HYNIC-TOC SPECT/CT scintigraphy in Graves' ophthalmopathy. Am J Nucl Med Mol Imaging 2012; 2: 242-7.
98. Cao TY, Yang Y, Gao YA, et al. High-quality water-soluble and surface-functionalized upconversion nanocrystals as luminescent probes for bioimaging. Biomaterials 2011; 32: 2959-68.
99. Wang C, Cheng LA, Liu ZA. Drug delivery with upconversion nanoparticles for multi-functional targeted cancer cell imaging and therapy. Biomaterials 2011; 32: 1110-20.
100. Hu H, Xiong L, Zhou J, et al. Multimodal-Luminescence Core-Shell Nanocomposites for Targeted Imaging of Tumor Cells. Chem Eur J 2009; 15: 3577-84.
101. Zhan QQ, Qian J, Liang HJ, et al. Using 915 nm Laser Excited Tm(3+)/Er(3+)/Ho(3+)-Doped NaYbF4 Upconversion Nanoparticles for in Vitro and Deeper in Vivo Bioimaging without Overheating Irradiation. ACS Nano 2011; 5: 3744-57.
102. Wang M, Mi CC, Wang WX, et al. Immunolabeling and NIR- Excited Fluorescent Imaging of HeLa Cells by Using NaYF(4):Yb,Er Upconversion Nanoparticles. ACS Nano 2009; 3: 1580-6.
103. Jiang S, Zhang Y, Lim KM, Sim EKW, Ye L. NIR-to-visible upconversion nanoparticles for fluorescent labeling and targeted delivery of siRNA. Nanotechnology 2009; 20: 155101-9.
104. Zhang P, Steelant W, Kumar M, Scholfield M. Versatile Photosensitizers for Photodynamic Therapy at Infrared Excitation. J Am Chem Soc 2007; 129: 4526-7.
105. Xiong L-Q, Chen Z-G, Yu M-X, et al. Synthesis, characterization, and in vivo targeted imaging of amine- functionalized rare-earth up-converting nanophosphors. Biomaterials 2009; 30: 5592-600.
106. Yu X-F, Sun Z, Li M, et al. Neurotoxin-conjugated upconversion nanoprobes for direct visualization of tumors under near-infrared irradiation. Biomaterials 2010; 31: 8724-31.
107. Cai WB, Chen XY. Multimodality molecular imaging of tumor angiogenesis. J Nucl Med 2008; 49: 113S-28S.
108. Cai WB, Shin DW, Chen K, et al. Peptide-labeled near- infrared quantum dots for imaging tumor vasculature in living subjects. Nano Lett 2006; 6: 669-76.
109. Dong N-N, Pedroni M, Piccinelli F, et al. NIR-to-NIR Two- Photon Excited CaF2:Tm3+,Yb3+ Nanoparticles: Multifunctional Nanoprobes for Highly Penetrating Fluorescence Bio-Imaging. ACS Nano 2011; 5: 8665-71.
110. Cheng L, Yang K, Shao MW, Lu XH, Liu Z. In vivo pharmacokinetics, long-term biodistribution and toxicology study of functionalized upconversion nanoparticles in mice. Nanomedicine 2011; 6: 1327-40.
111. Fang J, Nakamura H, Maeda H. The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev 2011; 63: 136-51.
112. Choi HS, Liu WH, Liu FB, et al. Design considerations for tumour-targeted nanoparticles. Nat Nanotechnol 2010; 5: 42-7.
113. Benezra M, Penate-Medina O, Zanzonico PB, et al. Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma. J Clin Invest 2011; 121: 2768-80.
114. Pelton M, Smith G, Scherer NF, Marcus RA. Evidence for a diffusion-controlled mechanism for fluorescence blinking of colloidal quantum dots. Proc Natl Acad Sci USA 2007; 104: 14249-54.
115. Yao J, Larson DR, Vishwasrao HD, Zipfel WR, Webb WW. Blinking and nonradiant dark fraction of water-soluble quantum dots in aqueous solution. Proc Natl Acad Sci USA 2005; 102: 14284-9.
116. Dubertret B, Skourides P, Norris DJ, et al. In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science 2002; 298: 1759-62.
117. Mattheakis LC, Dias JM, Choi YJ, et al. Optical coding of mammalian cells using semiconductor quantum dots. Anal Biochem 2004; 327: 200-8.
118. Ramachandran S, Merrill NE, Blick RH, van der Weide DW. Colloidal quantum dots initiating current bursts in lipid bilayers. Biosens Bioelectron 2005; 20: 2173-6.
119. Zhang F, Braun GB, Pallaoro A, et al. Mesoporous Multifunctional Upconversion Luminescent and Magnetic "Nanorattle" Materials for Targeted Chemotherapy. Nano Lett 2011; 12: 61-7.
120. Liu J, Bu W, Zhang S, et al. Controlled Synthesis of Uniform and Monodisperse Upconversion Core/Mesoporous Silica Shell Nanocomposites for Bimodal Imaging. Chem Eur J 2012; 18: 2335-41.
121. Gai S, Yang P, Li C, et al. Synthesis of Magnetic, Up- Conversion Luminescent, and Mesoporous Core-Shell- Structured Nanocomposites as Drug Carriers. Adv Funct Mater 2010; 20: 1166-72.
122. Dai Y, Ma Pa, Cheng Z, et al. Up-Conversion Cell Imaging and pH-Induced Thermally Controlled Drug Release from NaYF4:Yb3+/Er3+@Hydrogel Core-Shell Hybrid Microspheres. ACS Nano 2012; 6: 3327-38.
123. Carling C-J, Boyer J-C, Branda NR. Remote-Control Photoswitching Using NIR Light. J Am Chem Soc 2009; 131: 10838-39.
124. Boyer J-C, Carling C-J, Gates BD, Branda NR. Two-Way Photoswitching Using One Type of Near-Infrared Light, Upconverting Nanoparticles, and Changing Only the Light Intensity. J Am Chem Soc 2010; 132: 15766-72.
125. Carling C-J, Nourmohammadian F, Boyer J-C, Branda NR. Remote-Control Photorelease of Caged Compounds Using Near-Infrared Light and Upconverting Nanoparticles. Angew Chem Int Ed 2010; 49: 3782-5.
126. Wu W, Yao L, Yang T, et al. NIR-Light-Induced Deformation of Cross-Linked Liquid-Crystal Polymers Using Upconversion Nanophosphors. J Am Chem Soc 2011; 133: 15810-3.
127. Agostinis P, Berg K, Cengel KA, et al. Photodynamic therapy of cancer: An update. CA Cancer J Clin 2011; 61: 250-81.
128. Chatterjee DK, Yong Z. Upconverting nanoparticles as nanotransducers for photodynamic therapy in cancer cells. Nanomedicine 2008; 3: 73-82.
129. Qian HS, Guo HC, Ho PC-L, Mahendran R, Zhang Y. Mesoporous-Silica-Coated Up-Conversion Fluorescent Nanoparticles for Photodynamic Therapy. Small 2009; 5: 2285-90.
130. Ungun B, Prud'homme RK, Budijono SJ, et al. Nanofabricated upconversion nanoparticles for photodynamic therapy. Opt Express 2009; 17: 80-6.
131. Shan J, Budijono SJ, Hu G, et al. Pegylated Composite Nanoparticles Containing Upconverting Phosphors and meso-Tetraphenyl porphine (TPP) for Photodynamic Therapy. Adv Funct Mater 2011; 21: 2488-95.
132. Wang C, Tao H, Cheng L, Liu Z. Near-infrared light induced in vivo photodynamic therapy of cancer based on upconversion nanoparticles. Biomaterials 2011; 32: 6145-54.
133. Chen F, Zhang S, Bu W, et al. A Uniform Sub-50 nm-Sized Magnetic/Upconversion Fluorescent Bimodal Imaging Agent Capable of Generating Singlet Oxygen by Using a 980 nm Laser. Chemistry 2012; 18: 7082-90.
134. Vetrone F, Naccache R, Zamarrón A, et al. Temperature Sensing Using Fluorescent Nanothermometers. ACS Nano 2010; 4: 3254-8.
135. Achatz DE, Meier RJ, Fischer LH, Wolfbeis OS. Luminescent Sensing of Oxygen Using a Quenchable Probe and Upconverting Nanoparticles. Angew Chem Int Ed 2011; 50: 260-3.
136. Deng R, Xie X, Vendrell M, Chang Y-T, Liu X. Intracellular Glutathione Detection Using MnO2-Nanosheet-Modified Upconversion Nanoparticles. J Am Chem Soc 2011; 133: 20168-71.
137. Liu Q, Peng J, Sun L, Li F. High-Efficiency Upconversion Luminescent Sensing and Bioimaging of Hg(II) by Chromophoric Ruthenium Complex-Assembled Nanophosphors. ACS Nano 2011; 5: 8040-8.
138. Tu D, Liu L, Ju Q, et al. Time-Resolved FRET Biosensor Based on Amine-Functionalized Lanthanide-Doped NaYF4 Nanocrystals. Angew Chem Int Ed 2011; 50: 6306-10.